Immunotherapy showing significant advancements in lung cancer treatment
Phase 3 clinical trial of neoadjuvant nivolumab leads to practice-changing results
TB and COVID-19, a joint battle?
On World TB Day 2022, we are looking at how researchers from the McGill International TB Centre at the RI-MUHC are working to raise awareness and to put an end to TB.
What’s the signature of a healthy heart?
Instead of treating the “average person,” the Courtois Cardiovascular Signature Program aims to treat every person as a unique individual
Raquel del Carpio-O’Donovan elected Honorary President by the World Federation of Neuroradiological Societies
World-class neuroradiologist regards her career as “an enormous fortune”
Three renewed Canada Research Chairs for RI-MUHC researchers
Ahmad Haidar, Dennis Jensen and Ian Watson are part of the McGill University cohort of 17 new and renewed Canada Research Chairs
$2M to the MUHC Foundation for precision cancer care
BMO gift will help cancer researchers at the RI-MUHC develop the hospital’s precision oncology program
RI-MUHC research team leads new consortium to make healthcare data more accessible
The new Quebec SmartCare Consortium has received $10M to break down data silos and increase the...
Promising COVID-19 therapeutic drug to start phase 3 clinical trial in the United States
Recruitment of first U.S.-based patients in dapsone trial has started
RI-MUHC team studies a novel, fully automated insulin delivery system
A new publication in Lancet Digital Health describes an important step that may improve glucose control and quality of life for people with type 1...
Two members of the RI-MUHC elected fellows of the Canadian Academy of Health Sciences
Congratulations to Jean Bourbeau and Togas Tulandi!